SCHEMBL18103151

SCHEMBL18103151

CC(=O)Nc1ccc(Oc2ccc(C(=O)c3ccc(Oc4ccc(NC(C)=O)cc4)cc3)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.68
L3MBTL1 Q9Y468 2/20 0.68
KMT2A Q03164 5/20 0.61
MEN1 O00255 3/20 0.61
MTNR1A P48039 1/20 0.59
MTNR1B P49286 1/20 0.59
LMNA P02545 2/20 0.56
CYP1A2 P05177 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
SMN1; SMN2 Q16637 5/20 0.55
POLB P06746 1/20 0.55
HTT P42858 3/20 0.55
HPGD P15428 2/20 0.55
MAPT P10636 4/20 0.53
RAB9A P51151 3/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
NPC1 O15118 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6516221 0.90 KMT2A (0.73) ALDH1A1L3MBTL1KMT2AMEN1MTNR1A
SCHEMBL11507112 0.89 MAPT (0.70) ALDH1A1L3MBTL1KMT2AMEN1MTNR1A
SCHEMBL6304948 0.87 MEN1 (0.59) ALDH1A1L3MBTL1KMT2AMEN1MTNR1A
SCHEMBL3468387 0.87 MAPT (0.68) ALDH1A1L3MBTL1KMT2AMEN1MTNR1A
SCHEMBL6305740 0.86 SMN1; SMN2 (0.67) ALDH1A1KMT2AMEN1MTNR1AMTNR1B
SCHEMBL18826484 0.85 KMT2A (0.66) ALDH1A1L3MBTL1KMT2AMEN1MTNR1A
SCHEMBL17281686 0.84 L3MBTL1 (0.54) ALDH1A1L3MBTL1KMT2AMEN1MTNR1A
SCHEMBL2844063 0.83 KMT2A (0.77) ALDH1A1L3MBTL1KMT2AMEN1MTNR1A
SCHEMBL14384396 0.83 MTNR1A (0.76) ALDH1A1KMT2AMEN1MTNR1AMTNR1B
SCHEMBL171438 0.83 HPGD (0.71) ALDH1A1L3MBTL1KMT2AMEN1MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE FUJIFILM CORPORATION (JP) 2016-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE BRS3, RAD1, RAD51 ALDH1A1 1334/4885L3MBTL1 1817/4885KMT2A 2801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.